Over the last two months, Catasys (CATS) shares traded lower, drifting down on light volume. As I detailed in depth a few weeks ago, this selloff was the result of investor's expectations for a strong Q3 being about 3...
Tailwinds' Take: the inflection point seems to have been hit with October billings of $1.1M. Guidance for next year of $20M gives this 3X revenue, which is very inexpensive looking at the size of the opportunity in front of...
Tailwinds' Take: Today’s release distinguishes Catasys in the field...they are more aptly addressing the problem with dealing with addiction, depression and anxiety simultaneously. In addition, CATS is getting health plan support, which actually is putting more money towards treatment...
In a recent article, I discussed my model for Catasys and how it shed light on the fact that Q3 billings were going to be flat versus the increase that investors had been anticipating. The process of going through...
The market is a great discounting mechanism. Current share price is supposed to reflect future earnings, hence discounting the opportunity. Sometimes there is a wide gap between the expectations of the market and what the future really holds. When...
Today an article came out on Yahoo! Finance suggesting that Catasys would need to raise money in the near future. I won't go into their numbers, as they are quite wrong, to the point of being similar to Fake...
Tailwinds' Take: as evidenced by many recent articles, including today's WSJ, the opioid epidemic is one of the largest problems facing our country. Catasys' OnTrak program is a potential life saver for those suffering from addiction.  Catasys, Inc. (CATS), a provider...
In the quarter ended June 30, several institutions stepped up and purchased shares of Catasys. This is a first for the Company as, prior to then, there had been no real institutional support for the shares; before the June Q,...
Tailwinds' Take: Catasys is executing on their plan. Adding states to existing programs demonstrates that they are having success. Management's comments give increasing confidence to rapid growth in Q3 and beyond. Catasys, Inc. (CATS), a provider of proprietary predictive analytics...
Yesterday Catasys reported their second quarter earnings. The report itself wasn't overly impressive as, despite high year over year growth, numbers dropped slightly from the first quarter. This, however, was not unexpected by the market, as the Company has...